Vouliez-vous dire
main

Résultats de la recherche - 6 results

Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples.

cervical cancer screening is gaining international attention, although more data on the relative clinical accuracy of validated human papillomavirus (HPV) DNA tests on urine versus cervical samples are ...

Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI)

and quantitative outcomes of B1MG MLM assessment in Belgium and discuss their relevance to GDI. The insights gained from this study can be helpful for steering future policy directions and interventions ...

Management and 6-month outcome of patients with diabetic foot problems: results from a nationwide quality improvement initiative between 2005 and 2014

covering ulcer healing, lower-limb amputation and many other aspects of diabetic foot care. The cyclical audits and feedback allow DFC s to focus their QI efforts. Clear nationwide gains in care quality have ...

Comprehensive control of human papillomavirus infections and related diseases.

2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. In recent years, we have gained tremendous ...

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

cytology screening provides a further small gain in sensitivity at the expense of a considerable loss in specificity if positive by either test is referred to colposcopy, in comparison with HPV testing only. ...

Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.

provide important future health gains, cervical screening will need to be continued for the whole generation of women that is already infected with the HPV types included in the vaccine. Phase IV studies ...

QR code

QR code for this page URL